AA_substitution,relative_activity,standard_deviation,aaref,aaalt,aapos,#chr,pos(1-based),ref,alt,hg19_chr,hg19_pos(1-based),hg18_chr,hg18_pos(1-based),genename,Ensembl_geneid,Ensembl_transcriptid,Ensembl_proteinid,Uniprot_acc,SIFT_score,SIFT_converted_rankscore,SIFT_pred,Polyphen2_HDIV_score,Polyphen2_HDIV_rankscore,Polyphen2_HDIV_pred,Polyphen2_HVAR_score,Polyphen2_HVAR_rankscore,Polyphen2_HVAR_pred,MutPred_score,MutPred_rankscore,MutPred_protID,MutPred_AAchange,MutPred_Top5features
A16V,0.42,0.005,A,V,16,17,42536319,C,T,17,40688337,17,37941863,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.337,0.12837,T,0.001,0.07471,B,0.002,0.06944,B,0.367,0.37511,P54802,A16V,Gain of sheet (P = 0.0028); Loss of helix (P = 0.0068); Gain of loop (P = 0.024); Loss of disorder (P = 0.0493); Gain of catalytic residue at A16 (P = 0.1616)
V117A,,,V,A,117,17,42536622,T,C,17,40688640,17,37942166,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.004,0.65419,D,0.896,0.49324,P,0.386,0.44011,B,0.676,0.8139,P54802,V117A,Gain of disorder (P = 0.0245); Loss of stability (P = 0.0813); Gain of glycosylation at P118 (P = 0.091); Gain of helix (P = 0.132); Loss of loop (P = 0.2237)
P118S,0.5,0.071,P,S,118,17,42536624,C,T,17,40688642,17,37942168,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.448,0.09048,T,0.483,0.36807,P,0.084,0.2927,B,0.462,0.53066,P54802,P118S,Gain of glycosylation at P118 (P = 0.0179); Gain of helix (P = 0.132); Gain of phosphorylation at P118 (P = 0.1617); Gain of disorder (P = 0.1656); Loss of relative solvent accessibility (P = 0.1807)
Y131S,0.04,0.022,Y,S,131,17,42537406,A,C,17,40689424,17,37942950,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000590358,ENSP00000225927;ENSP00000466892,P54802;K7END1,0,0.91255,D,1,0.90584,D,0.991,0.79672,D,0.916,0.98422,P54802,Y131S,Loss of stability (P = 0.0197); Gain of disorder (P = 0.0271); Gain of loop (P = 0.1069); Gain of MoRF binding (P = 0.1096); Loss of helix (P = 0.1299)
V135G,0.21,0.045,V,G,135,17,42537418,T,G,17,40689436,17,37942962,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000590358,ENSP00000225927;ENSP00000466892,P54802;K7END1,0,0.91255,D,0.281,0.32101,B,0.139,0.33484,B,0.819,0.9326,P54802,V135G,Gain of relative solvent accessibility (P = 0.0082); Loss of stability (P = 0.026); Gain of loop (P = 0.0312); Loss of helix (P = 0.079); Gain of sheet (P = 0.0827)
T137M,0.25,0.061,T,M,137,17,42537424,C,T,17,40689442,17,37942968,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000590358,ENSP00000225927;ENSP00000466892,P54802;K7END1,0,0.91255,D,1,0.90584,D,0.998,0.88582,D,0.874,0.96529,P54802,T137M,Loss of sheet (P = 0.0315); Gain of helix (P = 0.0425); Gain of MoRF binding (P = 0.0994); Loss of loop (P = 0.1242); Gain of phosphorylation at Y132 (P = 0.3607)
S141T,0.34,0.026,S,T,141,17,42537435,T,A,17,40689453,17,37942979,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000590358,ENSP00000225927;ENSP00000466892,P54802;K7END1,0.185,0.2155,T,0.966,0.56202,D,0.773,0.56974,P,.,.,.,.,.
R152Q,0.35,0.071,R,Q,152,17,42537469,G,A,17,40689487,17,37943013,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000590358,ENSP00000225927;ENSP00000466892,P54802;K7END1,0.202,0.2023,T,0.507,0.37264,P,0.062,0.2693,B,.,.,.,.,.
I154T,0.04,0.031,I,T,154,17,42537475,T,C,17,40689493,17,37943019,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000590358,ENSP00000225927;ENSP00000466892,P54802;K7END1,0.001,0.7849,D,0.99,0.63424,D,0.906,0.64351,P,0.855,0.9549,P54802,I154T,Loss of stability (P = 0.0086); Loss of catalytic residue at L159 (P = 0.0762); Loss of MoRF binding (P = 0.078); Gain of phosphorylation at I154 (P = 0.3641); Loss of helix (P = 0.4835)
A158S,0.1,0.025,A,S,158,17,42537486,G,T,17,40689504,17,37943030,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000590358,ENSP00000225927;ENSP00000466892,P54802;K7END1,0.004,0.65419,D,0.964,0.55854,D,0.806,0.58437,P,0.798,0.91799,P54802,A158S,Loss of helix (P = 0.0304); Gain of loop (P = 0.0321); Gain of glycosylation at A158 (P = 0.1055); Loss of MoRF binding (P = 0.1168); Loss of stability (P = 0.4601)
S169N,0.76,0.091,S,N,169,17,42537520,G,A,17,40689538,17,37943064,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000590358,ENSP00000225927;ENSP00000466892,P54802;K7END1,0.287,0.15149,T,0.003,0.11197,B,0.003,0.087,B,0.595,0.72484,P54802,S169N,Gain of relative solvent accessibility (P = 0.09); Loss of glycosylation at S169 (P = 0.0947); Gain of solvent accessibility (P = 0.1422); Gain of MoRF binding (P = 0.2325); Loss of helix (P = 0.3949)
A181D,0.54,0.031,A,D,181,17,42538349,C,A,17,40690367,17,37943893,NAGLU;NAGLU;NAGLU,ENSG00000108784;ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587;ENST00000590358,ENSP00000225927;ENSP00000467836;ENSP00000466892,P54802;K7EQH9;K7END1,0.644,0.04943,T,0.608,0.3954,P,0.29,0.40682,B,.,.,.,.,.
G183A,0.11,0.036,G,A,183,17,42538355,G,C,17,40690373,17,37943899,NAGLU;NAGLU;NAGLU,ENSG00000108784;ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587;ENST00000590358,ENSP00000225927;ENSP00000467836;ENSP00000466892,P54802;K7EQH9;K7END1,0.076,0.34269,T,0.976,0.5831,D,0.812,0.58704,P,0.759,0.88806,P54802,G183A,Gain of helix (P = 0.0022); Loss of loop (P = 0.0031); Loss of stability (P = 0.0853); Loss of catalytic residue at L184 (P = 0.2708); Gain of MoRF binding (P = 0.3555)
N190S,0.69,0.08,N,S,190,17,42538376,A,G,17,40690394,17,37943920,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0.08,0.33585,T,0.068,0.23728,B,0.022,0.19653,B,.,.,.,.,.
F192L,0.28,0.033,F,L,192,17,42538381,T,C,17,40690399,17,37943925,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0.079,0.33753,T,0.011,0.15914,B,0.008,0.13708,B,0.804,0.92228,P54802,F192L,Gain of helix (P = 0.0854); Loss of stability (P = 0.1577); Loss of catalytic residue at F192 (P = 0.2287); Gain of relative solvent accessibility (P = 0.281); Loss of loop (P = 0.3664)
F192L,0.28,0.033,F,L,192,17,42538383,C,A,17,40690401,17,37943927,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0.079,0.33753,T,0.011,0.15914,B,0.008,0.13708,B,0.804,0.92228,P54802,F192L,Gain of helix (P = 0.0854); Loss of stability (P = 0.1577); Loss of catalytic residue at F192 (P = 0.2287); Gain of relative solvent accessibility (P = 0.281); Loss of loop (P = 0.3664)
F192L,0.28,0.033,F,L,192,17,42538383,C,G,17,40690401,17,37943927,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0.079,0.33753,T,0.011,0.15914,B,0.008,0.13708,B,0.804,0.92228,P54802,F192L,Gain of helix (P = 0.0854); Loss of stability (P = 0.1577); Loss of catalytic residue at F192 (P = 0.2287); Gain of relative solvent accessibility (P = 0.281); Loss of loop (P = 0.3664)
F198Y,0.44,0.032,F,Y,198,17,42538400,T,A,17,40690418,17,37943944,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0,0.91255,D,0.595,0.3919,P,0.347,0.42698,B,.,.,.,.,.
G202R,0.4,0.109,G,R,202,17,42538411,G,A,17,40690429,17,37943955,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0.142,0.25457,T,0.845,0.46707,P,0.421,0.45113,B,0.667,0.80493,P54802,G202R,Gain of helix (P = 0.0349); Gain of methylation at G202 (P = 0.0352); Loss of loop (P = 0.1242); Gain of MoRF binding (P = 0.136); Loss of catalytic residue at R203 (P = 0.2593)
G202R,0.4,0.109,G,R,202,17,42538411,G,C,17,40690429,17,37943955,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0.142,0.25457,T,0.845,0.46707,P,0.421,0.45113,B,0.667,0.80493,P54802,G202R,Gain of helix (P = 0.0349); Gain of methylation at G202 (P = 0.0352); Loss of loop (P = 0.1242); Gain of MoRF binding (P = 0.136); Loss of catalytic residue at R203 (P = 0.2593)
M204I,0.23,0.061,M,I,204,17,42538419,G,A,17,40690437,17,37943963,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0.002,0.72154,D,0.023,0.18885,B,0.021,0.19346,B,0.902,0.97859,P54802,M204I,Loss of methylation at R203 (P = 0.0536); Loss of helix (P = 0.1299); Loss of phosphorylation at T209 (P = 0.1469); Loss of loop (P = 0.2237); Loss of catalytic residue at M204 (P = 0.2584)
M204I,0.23,0.061,M,I,204,17,42538419,G,C,17,40690437,17,37943963,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0.002,0.72154,D,0.023,0.18885,B,0.021,0.19346,B,0.902,0.97859,P54802,M204I,Loss of methylation at R203 (P = 0.0536); Loss of helix (P = 0.1299); Loss of phosphorylation at T209 (P = 0.1469); Loss of loop (P = 0.2237); Loss of catalytic residue at M204 (P = 0.2584)
M204I,0.23,0.061,M,I,204,17,42538419,G,T,17,40690437,17,37943963,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0.002,0.72154,D,0.023,0.18885,B,0.021,0.19346,B,0.902,0.97859,P54802,M204I,Loss of methylation at R203 (P = 0.0536); Loss of helix (P = 0.1299); Loss of phosphorylation at T209 (P = 0.1469); Loss of loop (P = 0.2237); Loss of catalytic residue at M204 (P = 0.2584)
D211N,0.7,0.067,D,N,211,17,42538438,G,A,17,40690456,17,37943982,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0.006,0.61437,D,0.125,0.26866,B,0.053,0.25678,B,.,.,.,.,.
P216S,0.67,0.055,P,S,216,17,42538453,C,T,17,40690471,17,37943997,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0.616,0.05372,T,0,0.02946,B,0.002,0.06944,B,0.489,0.57402,P54802,P216S,Loss of catalytic residue at P215 (P = 0.0226); Loss of glycosylation at P216 (P = 0.0313); Gain of ubiquitination at K221 (P = 0.0985); Loss of methylation at K221 (P = 0.1293); Gain of disorder (P = 0.1451)
P216R,0.57,0.028,P,R,216,17,42538454,C,G,17,40690472,17,37943998,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0.566,0.06262,T,0,0.02946,B,0,0.01387,B,0.479,0.5581,P54802,P216R,Loss of catalytic residue at P215 (P = 0.0117); Loss of glycosylation at P216 (P = 0.0241); Gain of MoRF binding (P = 0.0336); Loss of ubiquitination at K221 (P = 0.052); Loss of helix (P = 0.1299)
Q222E,0.47,0.031,Q,E,222,17,42538471,C,G,17,40690489,17,37944015,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0.018,0.50676,D,0.768,0.43819,P,0.289,0.40655,B,0.877,0.96683,P54802,Q222E,Loss of MoRF binding (P = 0.0795); Loss of ubiquitination at K221 (P = 0.0877); Gain of relative solvent accessibility (P = 0.09); Loss of methylation at K221 (P = 0.0907); Gain of solvent accessibility (P = 0.0971)
Y224C,0.34,0.023,Y,C,224,17,42538478,A,G,17,40690496,17,37944022,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0.167,0.23095,T,0.992,0.64738,D,0.792,0.57793,P,0.621,0.75566,P54802,Y224C,Loss of helix (P = 0.0376); Gain of loop (P = 0.0435); Gain of methylation at K221 (P = 0.045); Loss of ubiquitination at K221 (P = 0.0992); Loss of phosphorylation at Y224 (P = 0.1068)
R228Q,0.53,0.064,R,Q,228,17,42538674,G,A,17,40690692,17,37944218,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0.661,0.04685,T,0.14,0.2754,B,0.027,0.21085,B,.,.,.,.,.
R228W,0.16,0.008,R,W,228,17,42538673,C,T,17,40690691,17,37944217,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0.003,0.68238,D,1,0.90584,D,0.908,0.64494,P,.,.,.,.,.
G237D,0.06,0.033,G,D,237,17,42538701,G,A,17,40690719,17,37944245,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0.001,0.7849,D,0.771,0.43934,P,0.36,0.43183,B,0.916,0.98422,P54802,G237D,Loss of catalytic residue at G237 (P = 0.046); Loss of helix (P = 0.079); Loss of MoRF binding (P = 0.1031); Gain of phosphorylation at T239 (P = 0.1931); Gain of solvent accessibility (P = 0.3194)
P243S,0.21,0.051,P,S,243,17,42538718,C,T,17,40690736,17,37944262,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0,0.91255,D,1,0.90584,D,1,0.97372,D,0.915,0.98385,P54802,P243S,Gain of helix (P = 0.0078); Loss of loop (P = 0.0084); Loss of catalytic residue at P243 (P = 0.0808); Loss of phosphorylation at T239 (P = 0.269); Gain of MoRF binding (P = 0.3916)
A244T,0.2,0.027,A,T,244,17,42538721,G,A,17,40690739,17,37944265,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0.003,0.68238,D,1,0.90584,D,0.996,0.84481,D,0.8,0.91943,P54802,A244T,Loss of helix (P = 0.0558); Gain of phosphorylation at A244 (P = 0.0561); Gain of loop (P = 0.1069); Gain of glycosylation at A244 (P = 0.1094); Gain of relative solvent accessibility (P = 0.2363)
E251K,0.18,0.087,E,K,251,17,42538742,G,A,17,40690760,17,37944286,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,1,0.00964,T,0.003,0.11197,B,0.003,0.087,B,0.463,0.53228,P54802,E251K,Gain of methylation at E251 (P = 0.028); Gain of sheet (P = 0.0344); Loss of helix (P = 0.0376); Gain of ubiquitination at E251 (P = 0.0592); Gain of MoRF binding (P = 0.0668)
V253I,1.13,0.041,V,I,253,17,42538748,G,A,17,40690766,17,37944292,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0.418,0.09896,T,0.001,0.07471,B,0.004,0.1009,B,0.419,0.46023,P54802,V253I,Gain of catalytic residue at V253 (P = 0.0392); Loss of sheet (P = 0.0457); Gain of helix (P = 0.0496); Loss of loop (P = 0.1242); Loss of methylation at R255 (P = 0.1768)
T254I,0.67,0.064,T,I,254,17,42538752,C,T,17,40690770,17,37944296,NAGLU;NAGLU,ENSG00000108784;ENSG00000108784,ENST00000225927;ENST00000591587,ENSP00000225927;ENSP00000467836,P54802;K7EQH9,0.186,0.21467,T,0.72,0.42342,P,0.434,0.45506,B,0.487,0.57084,P54802,T254I,Gain of sheet (P = 0.0149); Loss of helix (P = 0.0558); Loss of loop (P = 0.0986); Loss of methylation at R255 (P = 0.1285); Loss of catalytic residue at T254 (P = 0.1369)
V260I,0.69,0.028,V,I,260,17,42540963,G,A,17,40692981,17,37946507,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.064,0.36509,T,0.009,0.15093,B,0.01,0.14941,B,0.653,0.79059,P54802,V260I,Loss of sheet (P = 0.0817); Gain of ubiquitination at K264 (P = 0.1084); Gain of helix (P = 0.1736); Loss of methylation at R255 (P = 0.2227); Gain of loop (P = 0.2754)
N261S,0.72,0.03,N,S,261,17,42540967,A,G,17,40692985,17,37946511,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.128,0.26965,T,0.036,0.20732,B,0.017,0.1814,B,0.629,0.76468,P54802,N261S,Gain of sheet (P = 0.0477); Loss of loop (P = 0.1242); Loss of ubiquitination at K264 (P = 0.1278); Loss of solvent accessibility (P = 0.2668); Loss of relative solvent accessibility (P = 0.3219)
T263M,0.93,0.163,T,M,263,17,42540973,C,T,17,40692991,17,37946517,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.001,0.7849,D,0.997,0.70673,D,0.833,0.59784,P,0.628,0.76356,P54802,T263M,Loss of ubiquitination at K264 (P = 0.0498); Loss of sheet (P = 0.0817); Loss of loop (P = 0.2237); Gain of MoRF binding (P = 0.3333); Loss of methylation at K264 (P = 0.5409)
G269D,0.89,0.153,G,D,269,17,42540991,G,A,17,40693009,17,37946535,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.627,0.05198,T,0.947,0.53479,P,0.773,0.56974,P,0.626,0.76132,P54802,G269D,Gain of relative solvent accessibility (P = 0.09); Gain of ubiquitination at K264 (P = 0.1084); Loss of catalytic residue at W268 (P = 0.1312); Gain of solvent accessibility (P = 0.1376); Loss of sheet (P = 0.1398)
C273R,0.19,0.139,C,R,273,17,42541002,T,C,17,40693020,17,37946546,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.178,0.22138,T,0.973,0.57599,D,0.877,0.62241,P,0.704,0.84047,P54802,C273R,Gain of sheet (P = 0.0477); Gain of MoRF binding (P = 0.0602); Gain of disorder (P = 0.0892); Loss of catalytic residue at N272 (P = 0.1059); Loss of stability (P = 0.1749)
S276F,0.07,0.039,S,F,276,17,42541012,C,T,17,40693030,17,37946556,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.003,0.68238,D,0.993,0.65571,D,0.947,0.68407,D,0.754,0.88397,P54802,S276F,Gain of helix (P = 0.0225); Loss of glycosylation at S276 (P = 0.0823); Loss of loop (P = 0.1242); Loss of sheet (P = 0.1398); Loss of catalytic residue at S276 (P = 0.3662)
L281P,0.06,0.028,L,P,281,17,42541027,T,C,17,40693045,17,37946571,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.001,0.7849,D,0.995,0.67487,D,0.9,0.63913,P,0.804,0.92228,P54802,L281P,Gain of relative solvent accessibility (P = 0.0082); Loss of stability (P = 0.0148); Gain of loop (P = 0.024); Gain of solvent accessibility (P = 0.0256); Loss of sheet (P = 0.0483)
P283L,1.19,0.057,P,L,283,17,42541033,C,T,17,40693051,17,37946577,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.019,0.50132,D,0.731,0.42679,P,0.277,0.40197,B,0.665,0.80292,P54802,P283L,Loss of loop (P = 0.0073); Gain of helix (P = 0.0093); Loss of relative solvent accessibility (P = 0.0306); Loss of solvent accessibility (P = 0.0431); Loss of sheet (P = 0.1398)
I290V,0.21,0.035,I,V,290,17,42541053,A,G,17,40693071,17,37946597,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.296,0.14694,T,0,0.02946,B,0.002,0.06944,B,0.396,0.42249,P54802,I290V,Gain of sheet (P = 0.1208); Loss of helix (P = 0.1299); Gain of loop (P = 0.2754); Loss of catalytic residue at I290 (P = 0.3048); Loss of stability (P = 0.6111)
I291L,1.08,0.204,I,L,291,17,42541056,A,C,17,40693074,17,37946600,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.008,0.58626,D,0.549,0.38101,P,0.218,0.37679,B,0.701,0.8377,P54802,I291L,Loss of catalytic residue at L296 (P = 0.0511); Gain of helix (P = 0.0854); Loss of sheet (P = 0.1398); Loss of loop (P = 0.2237); Loss of phosphorylation at S293 (P = 0.6131)
L294F,0.96,0.088,L,F,294,17,42541065,C,T,17,40693083,17,37946609,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.042,0.41637,D,0.986,0.61523,D,0.907,0.64423,P,0.647,0.78427,P54802,L294F,Gain of sheet (P = 0.0344); Loss of helix (P = 0.0376); Loss of stability (P = 0.2535); Gain of loop (P = 0.2754); Loss of phosphorylation at S293 (P = 0.6162)
R297Q,1.05,0.172,R,Q,297,17,42541075,G,A,17,40693093,17,37946619,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.108,0.2942,T,0.928,0.51611,P,0.334,0.42203,B,.,.,.,.,.
I300T,0.92,0.242,I,T,300,17,42541084,T,C,17,40693102,17,37946628,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.507,0.0757,T,0.002,0.09854,B,0.003,0.087,B,.,.,.,.,.
D306G,0.58,0.06,D,G,306,17,42541102,A,G,17,40693120,17,37946646,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.086,0.3261,T,0.84,0.46486,P,0.653,0.52567,P,.,.,.,.,.
I308T,0.34,0.058,I,T,308,17,42541108,T,C,17,40693126,17,37946652,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.001,0.7849,D,0.974,0.57829,D,0.756,0.56253,P,0.684,0.82167,P54802,I308T,Loss of sheet (P = 0.0104); Loss of catalytic residue at I308 (P = 0.014); Gain of disorder (P = 0.0224); Loss of stability (P = 0.0307); Gain of loop (P = 0.0312)
G310A,0.68,0.109,G,A,310,17,42541114,G,C,17,40693132,17,37946658,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.024,0.47745,D,0.515,0.37421,P,0.248,0.38946,B,0.616,0.7499,P54802,G310A,Loss of loop (P = 0.0374); Gain of helix (P = 0.0425); Gain of catalytic residue at G310 (P = 0.0495); Loss of stability (P = 0.1769); Gain of phosphorylation at Y309 (P = 0.1983)
G310V,0.06,0.029,G,V,310,17,42541114,G,T,17,40693132,17,37946658,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.004,0.65419,D,0.72,0.42342,P,0.334,0.42203,B,0.624,0.75906,P54802,G310V,Gain of sheet (P = 0.0221); Loss of loop (P = 0.0374); Loss of disorder (P = 0.0766); Gain of helix (P = 0.132); Loss of phosphorylation at T313 (P = 0.1437)
S322L,0.74,0.118,S,L,322,17,42541150,C,T,17,40693168,17,37946694,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.009,0.5748,D,0.907,0.50062,P,0.735,0.5548,P,.,.,.,.,.
L327F,0.09,0.047,L,F,327,17,42541164,C,T,17,40693182,17,37946708,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.007,0.59928,D,1,0.90584,D,1,0.97372,D,0.752,0.88232,P54802,L327F,Loss of disorder (P = 0.1619); Loss of glycosylation at T332 (P = 0.1964); Gain of phosphorylation at S322 (P = 0.2312); Gain of catalytic residue at A330 (P = 0.3776); Loss of helix (P = 0.5596)
A329T,0.87,0.15,A,T,329,17,42541170,G,A,17,40693188,17,37946714,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.579,0.06011,T,0.046,0.21875,B,0.028,0.21332,B,0.557,0.67535,P54802,A329T,Gain of glycosylation at A329 (P = 0.0074); Loss of helix (P = 0.0444); Gain of loop (P = 0.0502); Gain of phosphorylation at A329 (P = 0.1514); Gain of disorder (P = 0.1587)
T332I,0.81,0.02,T,I,332,17,42541180,C,T,17,40693198,17,37946724,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.079,0.33753,T,0.122,0.26746,B,0.084,0.2927,B,0.494,0.58192,P54802,T332I,Loss of glycosylation at T332 (P = 0.0176); Loss of catalytic residue at T332 (P = 0.0278); Loss of phosphorylation at T332 (P = 0.0431); Loss of disorder (P = 0.0513); Gain of stability (P = 0.453)
V334I,0.76,0.093,V,I,334,17,42541185,G,A,17,40693203,17,37946729,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.493,0.0792,T,0.803,0.45133,P,0.228,0.38116,B,.,.,.,.,.
M338I,0.59,0.051,M,I,338,17,42541199,G,A,17,40693217,17,37946743,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.102,0.30235,T,0.497,0.37095,P,0.144,0.33818,B,0.703,0.83955,P54802,M338I,Loss of catalytic residue at V334 (P = 0.064); Loss of phosphorylation at Y335 (P = 0.1566); Loss of glycosylation at T339 (P = 0.2084); Gain of helix (P = 0.2294); Loss of disorder (P = 0.4353)
M338I,0.59,0.051,M,I,338,17,42541199,G,C,17,40693217,17,37946743,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.102,0.30235,T,0.497,0.37095,P,0.144,0.33818,B,0.703,0.83955,P54802,M338I,Loss of catalytic residue at V334 (P = 0.064); Loss of phosphorylation at Y335 (P = 0.1566); Loss of glycosylation at T339 (P = 0.2084); Gain of helix (P = 0.2294); Loss of disorder (P = 0.4353)
M338I,0.59,0.051,M,I,338,17,42541199,G,T,17,40693217,17,37946743,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.102,0.30235,T,0.497,0.37095,P,0.144,0.33818,B,0.703,0.83955,P54802,M338I,Loss of catalytic residue at V334 (P = 0.064); Loss of phosphorylation at Y335 (P = 0.1566); Loss of glycosylation at T339 (P = 0.2084); Gain of helix (P = 0.2294); Loss of disorder (P = 0.4353)
T339P,0.05,0.017,T,P,339,17,42541200,A,C,17,40693218,17,37946744,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.092,0.31682,T,0.002,0.09854,B,0.004,0.1009,B,0.474,0.55007,P54802,T339P,Loss of helix (P = 0.0104); Gain of loop (P = 0.0111); Gain of relative solvent accessibility (P = 0.0215); Gain of solvent accessibility (P = 0.0503); Loss of glycosylation at T339 (P = 0.0586)
A340T,0.95,0.01,A,T,340,17,42541203,G,A,17,40693221,17,37946747,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.567,0.06243,T,0.009,0.15093,B,0.01,0.14941,B,0.42,0.46187,P54802,A340T,Gain of glycosylation at A340 (P = 0.0106); Gain of relative solvent accessibility (P = 0.0479); Loss of helix (P = 0.0558); Gain of loop (P = 0.069); Gain of solvent accessibility (P = 0.0917)
L349F,0.08,0.027,L,F,349,17,42543051,C,T,17,40695069,17,37948595,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.037,0.43085,D,0.036,0.20732,B,0.037,0.23121,B,0.741,0.87311,P54802,L349F,Gain of catalytic residue at L349 (P = 0.3351); Loss of MoRF binding (P = 0.4219); Loss of stability (P = 0.5463); Loss of helix (P = 0.5596); Loss of disorder (P = 0.8253)
G351A,0.64,0.101,G,A,351,17,42543058,G,C,17,40695076,17,37948602,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.067,0.35918,T,1,0.90584,D,1,0.97372,D,.,.,.,.,.
F354S,0.07,0.01,F,S,354,17,42543067,T,C,17,40695085,17,37948611,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0,0.91255,D,1,0.90584,D,1,0.97372,D,0.871,0.96372,P54802,F354S,Loss of catalytic residue at F354 (P = 0.0224); Gain of relative solvent accessibility (P = 0.0479); Gain of disorder (P = 0.0855); Gain of solvent accessibility (P = 0.11); Loss of helix (P = 0.2022)
Q355K,0.65,0.112,Q,K,355,17,42543069,C,A,17,40695087,17,37948613,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.289,0.15047,T,0.837,0.46346,P,0.416,0.44962,B,0.606,0.73815,P54802,Q355K,Gain of methylation at Q355 (P = 0.003); Gain of ubiquitination at Q355 (P = 0.0185); Gain of MoRF binding (P = 0.0806); Gain of catalytic residue at Q350 (P = 0.2548); Loss of helix (P = 0.2662)
W361S,0.07,0.029,W,S,361,17,42543088,G,C,17,40695106,17,37948632,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0,0.91255,D,1,0.90584,D,1,0.97372,D,0.805,0.92299,P54802,W361S,Gain of disorder (P = 9e-04); Gain of relative solvent accessibility (P = 0.005); Gain of glycosylation at W361 (P = 0.0209); Gain of solvent accessibility (P = 0.0311); Loss of catalytic residue at W361 (P = 0.0377)
I366M,0.59,0.097,I,M,366,17,42543104,C,G,17,40695122,17,37948648,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.82,0.02958,T,0.097,0.25541,B,0.051,0.25434,B,0.662,0.79987,P54802,I366M,Gain of catalytic residue at I366 (P = 0.0048); Gain of methylation at R367 (P = 0.0411); Gain of MoRF binding (P = 0.1975); Loss of helix (P = 0.3949); Gain of disorder (P = 0.4059)
V369L,0.14,0.037,V,L,369,17,42543111,G,C,17,40695129,17,37948655,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,1,0.00964,T,0.014,0.16867,B,0.03,0.21741,B,0.574,0.69815,P54802,V369L,Loss of methylation at R367 (P = 0.1853); Loss of MoRF binding (P = 0.2292); Loss of helix (P = 0.3949); Gain of loop (P = 0.4248); Loss of catalytic residue at R367 (P = 0.6066)
V369L,0.14,0.037,V,L,369,17,42543111,G,T,17,40695129,17,37948655,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,1,0.00964,T,0.014,0.16867,B,0.03,0.21741,B,0.574,0.69815,P54802,V369L,Loss of methylation at R367 (P = 0.1853); Loss of MoRF binding (P = 0.2292); Loss of helix (P = 0.3949); Gain of loop (P = 0.4248); Loss of catalytic residue at R367 (P = 0.6066)
P374S,0.77,0.127,P,S,374,17,42543126,C,T,17,40695144,17,37948670,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0,0.91255,D,1,0.90584,D,1,0.97372,D,0.864,0.95995,P54802,P374S,Gain of helix (P = 0.0164); Loss of loop (P = 0.0203); Gain of MoRF binding (P = 0.054); Gain of catalytic residue at P374 (P = 0.06); Gain of methylation at R377 (P = 0.13)
R375H,0.4,0.064,R,H,375,17,42543130,G,A,17,40695148,17,37948674,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.563,0.06322,T,0.989,0.62824,D,0.704,0.543,P,0.671,0.80894,P54802,R375H,Loss of methylation at R375 (P = 0.0071); Loss of MoRF binding (P = 0.0951); Loss of solvent accessibility (P = 0.1177); Loss of sheet (P = 0.1398); Loss of helix (P = 0.1706)
R375C,0.25,0.023,R,C,375,17,42543129,C,T,17,40695147,17,37948673,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.187,0.21385,T,0.996,0.68779,D,0.867,0.61644,P,0.668,0.80594,P54802,R375C,Loss of methylation at R375 (P = 0.0071); Loss of sheet (P = 0.0126); Gain of catalytic residue at P374 (P = 0.0134); Loss of helix (P = 0.079); Loss of MoRF binding (P = 0.0813)
R377H,0.06,0.036,R,H,377,17,42543136,G,A,17,40695154,17,37948680,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.083,0.33091,T,0.495,0.37059,P,0.148,0.34065,B,.,.,.,.,.
R377C,0.15,0.048,R,C,377,17,42543135,C,T,17,40695153,17,37948679,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.001,0.7849,D,1,0.90584,D,0.964,0.71005,D,0.714,0.84955,P54802,R377C,Loss of sheet (P = 0.0126); Loss of methylation at R377 (P = 0.0198); Gain of catalytic residue at L378 (P = 0.0211); Gain of helix (P = 0.0496); Loss of loop (P = 0.0804)
A385V,0.03,0.019,A,V,385,17,42543160,C,T,17,40695178,17,37948704,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.003,0.68238,D,1,0.90584,D,0.999,0.92359,D,0.684,0.82167,P54802,A385V,Gain of sheet (P = 0.0043); Loss of helix (P = 0.0237); Loss of relative solvent accessibility (P = 0.0793); Loss of solvent accessibility (P = 0.1651); Loss of loop (P = 0.2237)
E386K,0.03,0.018,E,K,386,17,42543162,G,A,17,40695180,17,37948706,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.004,0.65419,D,1,0.90584,D,0.999,0.92359,D,0.743,0.8748,P54802,E386K,Gain of ubiquitination at E386 (P = 0.03); Gain of methylation at E386 (P = 0.0351); Gain of helix (P = 0.0696); Loss of stability (P = 0.0742); Loss of sheet (P = 0.1158)
R393H,0.85,0.145,R,H,393,17,42543184,G,A,17,40695202,17,37948728,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.197,0.20607,T,0.048,0.22112,B,0.017,0.1814,B,0.592,0.72112,P54802,R393H,Gain of glycosylation at T392 (P = 0.137); Loss of sheet (P = 0.1398); Loss of phosphorylation at T392 (P = 0.1426); Loss of stability (P = 0.2037); Gain of loop (P = 0.2045)
Q398K,0.5,0.016,Q,K,398,17,42543198,C,A,17,40695216,17,37948742,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.01,0.56456,D,0.061,0.2319,B,0.053,0.25678,B,0.601,0.73216,P54802,Q398K,Gain of methylation at Q398 (P = 2e-04); Gain of solvent accessibility (P = 0.0216); Gain of relative solvent accessibility (P = 0.0275); Gain of sheet (P = 0.0344); Gain of ubiquitination at Q398 (P = 0.0351)
G399V,0.05,0.025,G,V,399,17,42543202,G,T,17,40695220,17,37948746,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0,0.91255,D,1,0.90584,D,1,0.97372,D,0.89,0.9732,P54802,G399V,Gain of sheet (P = 0.0166); Loss of loop (P = 0.0203); Gain of helix (P = 0.0325); Loss of disorder (P = 0.1428); Loss of relative solvent accessibility (P = 0.3219)
W404C,0.02,0.018,W,C,404,17,42543218,G,C,17,40695236,17,37948762,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0,0.91255,D,1,0.90584,D,1,0.97372,D,0.852,0.95317,P54802,W404C,Gain of sheet (P = 0.0149); Loss of helix (P = 0.0376); Gain of loop (P = 0.0851); Gain of catalytic residue at L407 (P = 0.6015); Loss of MoRF binding (P = 0.6052)
W404C,0.02,0.018,W,C,404,17,42543218,G,T,17,40695236,17,37948762,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0,0.91255,D,1,0.90584,D,1,0.97372,D,0.852,0.95317,P54802,W404C,Gain of sheet (P = 0.0149); Loss of helix (P = 0.0376); Gain of loop (P = 0.0851); Gain of catalytic residue at L407 (P = 0.6015); Loss of MoRF binding (P = 0.6052)
H408Y,0.04,0.022,H,Y,408,17,42543228,C,T,17,40695246,17,37948772,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.001,0.7849,D,0.997,0.70673,D,0.924,0.65913,D,.,.,.,.,.
E421K,0.33,0.056,E,K,421,17,42543267,G,A,17,40695285,17,37948811,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.083,0.33091,T,0.638,0.40359,P,0.321,0.4176,B,0.657,0.79473,P54802,E421K,Gain of ubiquitination at E421 (P = 0.0177); Gain of solvent accessibility (P = 0.0354); Gain of relative solvent accessibility (P = 0.0479); Gain of glycosylation at E421 (P = 0.098); Loss of helix (P = 0.1299)
G426A,0.09,0.021,G,A,426,17,42543283,G,C,17,40695301,17,37948827,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.146,0.25055,T,1,0.90584,D,1,0.97372,D,0.721,0.85579,P54802,G426A,Gain of helix (P = 0.027); Loss of sheet (P = 0.0483); Loss of catalytic residue at G426 (P = 0.1183); Loss of disorder (P = 0.1208); Gain of methylation at R431 (P = 0.143)
R431C,0.05,0.021,R,C,431,17,42543297,C,T,17,40695315,17,37948841,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.002,0.72154,D,1,0.90584,D,0.945,0.68163,D,0.652,0.78954,P54802,R431C,Gain of sheet (P = 0.0043); Loss of solvent accessibility (P = 0.0079); Loss of helix (P = 0.0123); Loss of methylation at R431 (P = 0.0165); Gain of loop (P = 0.0312)
N435T,0.3,0.048,N,T,435,17,42543310,A,C,17,40695328,17,37948854,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.007,0.59928,D,1,0.90584,D,0.995,0.8317,D,0.75,0.88066,P54802,N435T,Gain of glycosylation at N435 (P = 0.0483); Loss of helix (P = 0.0558); Gain of phosphorylation at T437 (P = 0.1278); Loss of methylation at R431 (P = 0.1463); Gain of sheet (P = 0.1945)
T437S,0.96,0.071,T,S,437,17,42543315,A,T,17,40695333,17,37948859,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.008,0.58626,D,0.997,0.70673,D,0.905,0.6426,P,0.757,0.88644,P54802,T437S,Loss of sheet (P = 0.0315); Gain of disorder (P = 0.0523); Gain of loop (P = 0.069); Loss of glycosylation at S436 (P = 0.0732); Loss of phosphorylation at T437 (P = 0.1226)
T437S,0.96,0.071,T,S,437,17,42543316,C,G,17,40695334,17,37948860,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.008,0.58626,D,0.997,0.70673,D,0.905,0.6426,P,0.757,0.88644,P54802,T437S,Loss of sheet (P = 0.0315); Gain of disorder (P = 0.0523); Gain of loop (P = 0.069); Loss of glycosylation at S436 (P = 0.0732); Loss of phosphorylation at T437 (P = 0.1226)
T441M,0.49,0.048,T,M,441,17,42543328,C,T,17,40695346,17,37948872,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.077,0.34095,T,0.973,0.57599,D,0.565,0.49728,P,.,.,.,.,.
A444V,0.93,0.067,A,V,444,17,42543337,C,T,17,40695355,17,37948881,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.171,0.22746,T,0.028,0.19712,B,0.025,0.20508,B,0.739,0.87142,P54802,A444V,Loss of disorder (P = 0.0846); Gain of sheet (P = 0.1451); Loss of helix (P = 0.2022); Loss of loop (P = 0.2897); Gain of catalytic residue at A444 (P = 0.3248)
A444D,0.04,0.012,A,D,444,17,42543337,C,A,17,40695355,17,37948881,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.028,0.46129,D,0.947,0.53479,P,0.691,0.53831,P,0.716,0.85134,P54802,A444D,Gain of relative solvent accessibility (P = 0.0479); Gain of disorder (P = 0.0566); Gain of solvent accessibility (P = 0.0704); Gain of phosphorylation at T441 (P = 0.1394); Gain of helix (P = 0.1736)
P445S,0.04,0.011,P,S,445,17,42543339,C,T,17,40695357,17,37948883,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.515,0.07378,T,1,0.90584,D,0.997,0.86255,D,0.784,0.90765,P54802,P445S,Loss of loop (P = 0.0288); Gain of helix (P = 0.0496); Gain of disorder (P = 0.0787); Loss of relative solvent accessibility (P = 0.0793); Gain of sheet (P = 0.0827)
S449N,0.21,0.065,S,N,449,17,42543352,G,A,17,40695370,17,37948896,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,1,0.00964,T,0.002,0.09854,B,0.004,0.1009,B,.,.,.,.,.
V454F,0.04,0.017,V,F,454,17,42543366,G,T,17,40695384,17,37948910,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.002,0.72154,D,0.991,0.6407,D,0.926,0.66095,D,0.755,0.8848,P54802,V454F,Loss of catalytic residue at V454 (P = 0.0168); Loss of disorder (P = 0.1815); Gain of helix (P = 0.2059); Loss of phosphorylation at Y455 (P = 0.4191); Loss of loop (P = 0.4786)
Y455S,0.03,0.023,Y,S,455,17,42543370,A,C,17,40695388,17,37948914,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0,0.91255,D,1,0.90584,D,0.995,0.8317,D,0.887,0.97179,P54802,Y455S,Gain of disorder (P = 0.0172); Loss of phosphorylation at Y455 (P = 0.0307); Loss of catalytic residue at Y455 (P = 0.067); Gain of glycosylation at S456 (P = 0.1013); Gain of helix (P = 0.2059)
S456F,0.23,0.042,S,F,456,17,42543373,C,T,17,40695391,17,37948917,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.005,0.63226,D,0.836,0.46303,P,0.462,0.46509,P,0.715,0.85045,P54802,S456F,Loss of disorder (P = 0.1102); Loss of catalytic residue at S456 (P = 0.1363); Loss of glycosylation at S456 (P = 0.2016); Gain of helix (P = 0.2294); Loss of loop (P = 0.4786)
G462R,0.03,0.026,G,R,462,17,42543390,G,C,17,40695408,17,37948934,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.005,0.63226,D,1,0.90584,D,0.993,0.8111,D,0.593,0.72236,P54802,G462R,Gain of helix (P = 0.0082); Loss of loop (P = 0.0084); Gain of MoRF binding (P = 0.0834); Loss of ubiquitination at K465 (P = 0.1403); Loss of methylation at K465 (P = 0.179)
R464Q,0.03,0.015,R,Q,464,17,42543397,G,A,17,40695415,17,37948941,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.121,0.27783,T,0.973,0.57599,D,0.434,0.45506,B,.,.,.,.,.
S477T,1.01,0.077,S,T,477,17,42543436,G,C,17,40695454,17,37948980,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.597,0.05686,T,0.336,0.33356,B,0.129,0.32841,B,.,.,.,.,.
A479T,0.2,0.043,A,T,479,17,42543441,G,A,17,40695459,17,37948985,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.112,0.289,T,0.998,0.7322,D,0.971,0.72444,D,.,.,.,.,.
A480T,0.43,0.077,A,T,480,17,42543444,G,A,17,40695462,17,37948988,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.812,0.0302,T,0.038,0.21002,B,0.014,0.16862,B,.,.,.,.,.
R481W,0.09,0.014,R,W,481,17,42543447,C,T,17,40695465,17,37948991,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0,0.91255,D,0.999,0.77913,D,0.861,0.61279,P,.,.,.,.,.
P488L,0.39,0.075,P,L,488,17,42543469,C,T,17,40695487,17,37949013,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.199,0.20456,T,0.874,0.48047,P,0.136,0.3327,B,0.62,0.75452,P54802,P488L,Loss of loop (P = 0.0128); Gain of helix (P = 0.027); Gain of MoRF binding (P = 0.0429); Loss of disorder (P = 0.0481); Loss of glycosylation at S486 (P = 0.1379)
A490T,0.58,0.06,A,T,490,17,42543474,G,A,17,40695492,17,37949018,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.299,0.14546,T,0.194,0.29493,B,0.054,0.25828,B,0.56,0.67946,P54802,A490T,Loss of helix (P = 0.0123); Gain of loop (P = 0.0166); Gain of phosphorylation at A490 (P = 0.0851); Loss of MoRF binding (P = 0.1258); Loss of glycosylation at S486 (P = 0.175)
G491A,0.67,0.098,G,A,491,17,42543478,G,C,17,40695496,17,37949022,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.692,0.04277,T,0.001,0.07471,B,0.003,0.087,B,0.379,0.39469,P54802,G491A,Gain of helix (P = 0.027); Loss of loop (P = 0.0288); Loss of catalytic residue at G491 (P = 0.0622); Gain of glycosylation at S486 (P = 0.1023); Loss of MoRF binding (P = 0.1433)
A493V,0.18,0.033,A,V,493,17,42543484,C,T,17,40695502,17,37949028,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.002,0.72154,D,1,0.90584,D,0.997,0.86255,D,0.907,0.98069,P54802,A493V,Loss of helix (P = 0.028); Gain of loop (P = 0.0312); Gain of MoRF binding (P = 0.0948); Loss of disorder (P = 0.1508); Loss of catalytic residue at A493 (P = 0.4058)
L496P,0.05,0.026,L,P,496,17,42543493,T,C,17,40695511,17,37949037,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.081,0.33418,T,0.999,0.77913,D,0.985,0.76457,D,0.803,0.92157,P54802,L496P,Loss of stability (P = 0.0198); Loss of helix (P = 0.0304); Gain of loop (P = 0.0321); Gain of relative solvent accessibility (P = 0.0479); Loss of MoRF binding (P = 0.066)
R499W,0.25,0.017,R,W,499,17,42543501,C,T,17,40695519,17,37949045,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.003,0.68238,D,1,0.90584,D,0.956,0.69739,D,.,.,.,.,.
R499Q,0.53,0.105,R,Q,499,17,42543502,G,A,17,40695520,17,37949046,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.286,0.15201,T,0.53,0.37698,P,0.048,0.24975,B,.,.,.,.,.
N503S,0.33,0.04,N,S,503,17,42543514,A,G,17,40695532,17,37949058,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.005,0.63226,D,0.998,0.7322,D,0.953,0.69275,D,0.785,0.9084,P54802,N503S,Gain of disorder (P = 0.0607); Loss of MoRF binding (P = 0.1062); Loss of loop (P = 0.1242); Loss of helix (P = 0.1299); Loss of solvent accessibility (P = 0.1362)
G506E,0.55,0.057,G,E,506,17,42543523,G,A,17,40695541,17,37949067,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.08,0.33585,T,0.72,0.42342,P,0.517,0.48105,P,0.636,0.77242,P54802,G506E,Gain of helix (P = 0.0199); Loss of MoRF binding (P = 0.0505); Loss of loop (P = 0.0512); Gain of disorder (P = 0.0867); Loss of methylation at R510 (P = 0.1217)
C509Y,0.37,0.025,C,Y,509,17,42543532,G,A,17,40695550,17,37949076,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,1,0.00964,T,0.007,0.14184,B,0.015,0.17295,B,.,.,.,.,.
N513S,0.05,0.017,N,S,513,17,42543544,A,G,17,40695562,17,37949088,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.03,0.45393,D,0.992,0.64738,D,0.921,0.65636,D,.,.,.,.,.
R514H,0.96,0.112,R,H,514,17,42543547,G,A,17,40695565,17,37949091,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.422,0.09776,T,0.017,0.17573,B,0.007,0.12992,B,0.578,0.70335,P54802,R514H,Loss of MoRF binding (P = 0.0407); Loss of methylation at R514 (P = 0.1018); Gain of disorder (P = 0.1567); Gain of loop (P = 0.2045); Gain of catalytic residue at R514 (P = 0.2093)
R514C,0.51,0.082,R,C,514,17,42543546,C,T,17,40695564,17,37949090,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.014,0.53172,D,0.999,0.77913,D,0.908,0.64494,P,0.6,0.73095,P54802,R514C,Loss of disorder (P = 0.0081); Loss of MoRF binding (P = 0.0277); Loss of methylation at R514 (P = 0.1018); Gain of loop (P = 0.2045); Loss of phosphorylation at S515 (P = 0.205)
S522F,0.19,0.07,S,F,522,17,42543571,C,T,17,40695589,17,37949115,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.011,0.5553,D,1,0.90584,D,0.999,0.92359,D,0.674,0.81192,P54802,S522F,Loss of disorder (P = 0.0053); Loss of phosphorylation at S522 (P = 0.0341); Loss of sheet (P = 0.0457); Loss of glycosylation at S522 (P = 0.0587); Gain of helix (P = 0.0854)
Q524R,0.86,0.09,Q,R,524,17,42543577,A,G,17,40695595,17,37949121,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.404,0.10345,T,0.007,0.14184,B,0.01,0.14941,B,0.636,0.77242,P54802,Q524R,Gain of MoRF binding (P = 0.0157); Loss of sheet (P = 0.0817); Gain of glycosylation at S522 (P = 0.09); Gain of phosphorylation at S522 (P = 0.1041); Gain of methylation at Q524 (P = 0.1127)
R533Q,0.56,0.094,R,Q,533,17,42543604,G,A,17,40695622,17,37949148,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.347,0.12428,T,0.068,0.23728,B,0.009,0.143,B,0.436,0.48815,P54802,R533Q,Loss of MoRF binding (P = 0.0497); Gain of helix (P = 0.062); Loss of sheet (P = 0.0817); Loss of loop (P = 0.2237); Gain of catalytic residue at R533 (P = 0.2328)
V536M,0.45,0.113,V,M,536,17,42543612,G,A,17,40695630,17,37949156,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.013,0.539,D,0.997,0.70673,D,0.969,0.72001,D,0.735,0.868,P54802,V536M,Gain of helix (P = 0.062); Loss of loop (P = 0.0804); Gain of MoRF binding (P = 0.0981); Loss of sheet (P = 0.1158); Gain of phosphorylation at Y531 (P = 0.4309)
R541Q,0.4,0.056,R,Q,541,17,42543628,G,A,17,40695646,17,37949172,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.544,0.06713,T,0.988,0.62325,D,0.613,0.51171,P,.,.,.,.,.
L542R,0.47,0.068,L,R,542,17,42543631,T,G,17,40695649,17,37949175,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.044,0.41096,D,0.998,0.7322,D,0.977,0.7382,D,0.776,0.90153,P54802,L542R,Loss of stability (P = 0.0088); Gain of MoRF binding (P = 0.0099); Gain of phosphorylation at T545 (P = 0.0512); Gain of solvent accessibility (P = 0.0584); Gain of disorder (P = 0.0614)
L542P,0.05,0.047,L,P,542,17,42543631,T,C,17,40695649,17,37949175,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.026,0.4691,D,0.999,0.77913,D,0.989,0.78396,D,0.773,0.8992,P54802,L542P,Loss of stability (P = 0.0024); Gain of relative solvent accessibility (P = 0.0215); Gain of disorder (P = 0.0422); Loss of helix (P = 0.0444); Gain of solvent accessibility (P = 0.0503)
A547T,0.57,0.088,A,T,547,17,42543645,G,A,17,40695663,17,37949189,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.279,0.15561,T,0.014,0.16867,B,0.019,0.18783,B,0.496,0.58507,P54802,A547T,Gain of relative solvent accessibility (P = 0.0479); Gain of glycosylation at S546 (P = 0.0684); Gain of catalytic residue at A547 (P = 0.0909); Gain of solvent accessibility (P = 0.0917); Gain of phosphorylation at A547 (P = 0.1191)
A555T,0.97,0.088,A,T,555,17,42543669,G,A,17,40695687,17,37949213,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,1,0.00964,T,0.033,0.2035,B,0.007,0.12992,B,0.506,0.60065,P54802,A555T,Loss of helix (P = 0.0196); Gain of loop (P = 0.0312); Gain of phosphorylation at A555 (P = 0.0609); Gain of glycosylation at A555 (P = 0.0786); Gain of relative solvent accessibility (P = 0.09)
R557L,0.48,0.05,R,L,557,17,42543676,G,T,17,40695694,17,37949220,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.089,0.32141,T,0.064,0.23455,B,0.066,0.27432,B,0.718,0.85313,P54802,R557L,Loss of catalytic residue at R557 (P = 0.0497); Loss of loop (P = 0.0804); Loss of disorder (P = 0.1184); Gain of helix (P = 0.132); Gain of glycosylation at S553 (P = 0.2381)
R557C,0.48,0.086,R,C,557,17,42543675,C,T,17,40695693,17,37949219,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.001,0.7849,D,1,0.90584,D,0.938,0.6735,D,0.768,0.89526,P54802,R557C,Loss of disorder (P = 0.0628); Loss of catalytic residue at R557 (P = 0.1643); Loss of helix (P = 0.1706); Gain of glycosylation at S553 (P = 0.2052); Loss of phosphorylation at T552 (P = 0.2352)
D559N,0.04,0.029,D,N,559,17,42543681,G,A,17,40695699,17,37949225,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.022,0.48642,D,1,0.90584,D,1,0.97372,D,0.913,0.98309,P54802,D559N,Gain of helix (P = 0.0425); Loss of loop (P = 0.0512); Loss of stability (P = 0.1503); Loss of disorder (P = 0.3173); Gain of methylation at R557 (P = 0.4184)
D559H,0.07,0.012,D,H,559,17,42543681,G,C,17,40695699,17,37949225,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.001,0.7849,D,1,0.90584,D,1,0.97372,D,0.907,0.98069,P54802,D559H,Gain of helix (P = 0.0425); Loss of loop (P = 0.0512); Gain of catalytic residue at L561 (P = 0.1354); Loss of stability (P = 0.1479); Gain of disorder (P = 0.21)
L563H,0.07,0.022,L,H,563,17,42543694,T,A,17,40695712,17,37949238,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.001,0.7849,D,0.987,0.61912,D,0.819,0.59018,P,0.773,0.8992,P54802,L563H,Loss of stability (P = 0.0233); Loss of catalytic residue at Q566 (P = 0.0862); Gain of relative solvent accessibility (P = 0.1259); Gain of solvent accessibility (P = 0.199); Gain of phosphorylation at Y558 (P = 0.2402)
V568G,0.13,0.028,V,G,568,17,42543709,T,G,17,40695727,17,37949253,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.001,0.7849,D,0.326,0.33151,B,0.197,0.36707,B,0.817,0.93125,P54802,V568G,Loss of stability (P = 0.0198); Loss of catalytic residue at Q566 (P = 0.0739); Gain of disorder (P = 0.1009); Gain of phosphorylation at S573 (P = 0.3064); Gain of methylation at R565 (P = 0.5765)
S573G,0.57,0.034,S,G,573,17,42543723,A,G,17,40695741,17,37949267,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.097,0.30943,T,0.959,0.55135,D,0.714,0.54635,P,.,.,.,.,.
Y575C,0.52,0.032,Y,C,575,17,42543730,A,G,17,40695748,17,37949274,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.102,0.30235,T,0.125,0.26866,B,0.059,0.26602,B,0.542,0.65434,P54802,Y575C,Loss of disorder (P = 0.1117); Loss of helix (P = 0.1706); Gain of loop (P = 0.3485); Loss of phosphorylation at S573 (P = 0.3531); Loss of stability (P = 0.4011)
G595R,0.82,0.111,G,R,595,17,42543789,G,A,17,40695807,17,37949333,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.16,0.23721,T,0.999,0.77913,D,0.971,0.72444,D,0.592,0.72112,P54802,G595R,Gain of methylation at G595 (P = 0.0178); Gain of helix (P = 0.0496); Loss of loop (P = 0.0512); Gain of MoRF binding (P = 0.1159); Loss of catalytic residue at A594 (P = 0.1544)
G595R,0.82,0.111,G,R,595,17,42543789,G,C,17,40695807,17,37949333,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.16,0.23721,T,0.999,0.77913,D,0.971,0.72444,D,0.592,0.72112,P54802,G595R,Gain of methylation at G595 (P = 0.0178); Gain of helix (P = 0.0496); Loss of loop (P = 0.0512); Gain of MoRF binding (P = 0.1159); Loss of catalytic residue at A594 (P = 0.1544)
G596C,1.02,0.073,G,C,596,17,42543792,G,T,17,40695810,17,37949336,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.011,0.5553,D,1,0.90584,D,1,0.97372,D,.,.,.,.,.
V597I,1.02,0.129,V,I,597,17,42543795,G,A,17,40695813,17,37949339,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.435,0.09401,T,0.037,0.20876,B,0.012,0.16012,B,.,.,.,.,.
V597L,0.66,0.129,V,L,597,17,42543795,G,C,17,40695813,17,37949339,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.712,0.0402,T,0.017,0.17573,B,0.02,0.19048,B,0.371,0.38163,P54802,V597L,Loss of catalytic residue at V597 (P = 0.0371); Gain of methylation at R593 (P = 0.142); Gain of helix (P = 0.2059); Loss of MoRF binding (P = 0.4324); Gain of disorder (P = 0.458)
E608K,0.44,0.075,E,K,608,17,42543828,G,A,17,40695846,17,37949372,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.806,0.03068,T,0.007,0.14184,B,0.005,0.11217,B,0.453,0.51598,P54802,E608K,Gain of ubiquitination at E608 (P = 0.0203); Gain of helix (P = 0.0854); Gain of MoRF binding (P = 0.2523); Gain of phosphorylation at S612 (P = 0.2722); Loss of disorder (P = 0.3637)
R615C,0.17,0.048,R,C,615,17,42543849,C,T,17,40695867,17,37949393,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.051,0.39334,T,0.998,0.7322,D,0.761,0.56482,P,0.609,0.74171,P54802,R615C,Loss of solvent accessibility (P = 0.1077); Loss of phosphorylation at S614 (P = 0.1079); Loss of disorder (P = 0.1496); Loss of helix (P = 0.1706); Loss of stability (P = 0.1753)
S620G,0.93,0.073,S,G,620,17,42543864,A,G,17,40695882,17,37949408,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.327,0.13262,T,0.001,0.07471,B,0.005,0.11217,B,0.54,0.65149,P54802,S620G,Loss of helix (P = 0.0376); Gain of loop (P = 0.0435); Loss of stability (P = 0.0628); Gain of catalytic residue at S620 (P = 0.1824); Loss of phosphorylation at S620 (P = 0.2271)
R626Q,0.29,0.046,R,Q,626,17,42543883,G,A,17,40695901,17,37949427,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.068,0.35726,T,0.962,0.55554,D,0.387,0.44046,B,.,.,.,.,.
R626G,0.26,0.075,R,G,626,17,42543882,C,G,17,40695900,17,37949426,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.002,0.72154,D,0.996,0.68779,D,0.926,0.66095,D,0.786,0.90915,P54802,R626G,Gain of catalytic residue at A625 (P = 0.0347); Loss of stability (P = 0.1096); Loss of glycosylation at S631 (P = 0.1488); Loss of phosphorylation at S631 (P = 0.2034); Loss of helix (P = 0.2271)
A627V,0.08,0.001,A,V,627,17,42543886,C,T,17,40695904,17,37949430,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.168,0.23007,T,0.015,0.17086,B,0.012,0.16012,B,.,.,.,.,.
A628V,0.87,0.042,A,V,628,17,42543889,C,T,17,40695907,17,37949433,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.233,0.18122,T,0.007,0.14184,B,0.005,0.11217,B,0.574,0.69815,P54802,A628V,Loss of disorder (P = 0.064); Loss of helix (P = 0.079); Gain of loop (P = 0.1069); Loss of phosphorylation at S631 (P = 0.1369); Loss of glycosylation at S631 (P = 0.1651)
V630G,1.11,0.088,V,G,630,17,42543895,T,G,17,40695913,17,37949439,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.357,0.12032,T,0.521,0.37531,P,0.197,0.36707,B,.,.,.,.,.
V630I,0.77,0.065,V,I,630,17,42543894,G,A,17,40695912,17,37949438,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.204,0.20078,T,0.309,0.32767,B,0.138,0.33406,B,0.442,0.49797,P54802,V630I,Gain of glycosylation at S631 (P = 0.1588); Loss of disorder (P = 0.1895); Loss of phosphorylation at S631 (P = 0.2256); Loss of catalytic residue at V630 (P = 0.4263); Loss of methylation at R626 (P = 0.5204)
A633G,0.71,0.119,A,G,633,17,42543904,C,G,17,40695922,17,37949448,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.347,0.12428,T,0.669,0.41149,P,0.192,0.36449,B,0.498,0.58821,P54802,A633G,Gain of loop (P = 3e-04); Loss of helix (P = 0.0017); Gain of relative solvent accessibility (P = 0.0023); Loss of stability (P = 0.051); Gain of solvent accessibility (P = 0.0514)
D636N,0.69,0.086,D,N,636,17,42543912,G,A,17,40695930,17,37949456,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.491,0.07969,T,0.567,0.38485,P,0.065,0.27321,B,.,.,.,.,.
Q640R,0.79,0.131,Q,R,640,17,42543925,A,G,17,40695943,17,37949469,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.036,0.43393,D,0.023,0.18885,B,0.008,0.13708,B,0.528,0.63399,P54802,Q640R,Gain of sheet (P = 0.0827); Gain of phosphorylation at S642 (P = 0.0835); Loss of helix (P = 0.1706); Loss of disorder (P = 0.2143); Loss of solvent accessibility (P = 0.3854)
Q645P,0.05,0.039,Q,P,645,17,42543940,A,C,17,40695958,17,37949484,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0,0.91255,D,1,0.90584,D,0.999,0.92359,D,0.864,0.95995,P54802,Q645P,Gain of loop (P = 0.0166); Loss of sheet (P = 0.0357); Loss of helix (P = 0.0444); Loss of stability (P = 0.2416); Loss of disorder (P = 0.2601)
W649S,0.03,0.016,W,S,649,17,42543952,G,C,17,40695970,17,37949496,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0,0.91255,D,1,0.90584,D,1,0.97372,D,0.883,0.96983,P54802,W649S,Gain of disorder (P = 0.0022); Gain of sheet (P = 0.039); Gain of relative solvent accessibility (P = 0.0479); Gain of glycosylation at W649 (P = 0.0674); Gain of loop (P = 0.0851)
P673S,0.25,0.045,P,S,673,17,42544023,C,T,17,40696041,17,37949567,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.005,0.63226,D,0.92,0.51019,P,0.551,0.4927,P,0.696,0.83305,P54802,P673S,Gain of helix (P = 0.0093); Loss of loop (P = 0.0128); Gain of MoRF binding (P = 0.0811); Gain of methylation at R676 (P = 0.1969); Gain of catalytic residue at P673 (P = 0.2168)
R676W,0.26,0.053,R,W,676,17,42544032,C,T,17,40696050,17,37949576,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.019,0.50132,D,0.996,0.68779,D,0.663,0.52893,P,0.767,0.89447,P54802,R676W,Loss of methylation at R676 (P = 0.0469); Loss of helix (P = 0.1706); Gain of catalytic residue at E680 (P = 0.1922); Gain of loop (P = 0.2045); Loss of MoRF binding (P = 0.3323)
A681V,0.86,0.045,A,V,681,17,42544048,C,T,17,40696066,17,37949592,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.478,0.08286,T,0.529,0.37682,P,0.041,0.23986,B,0.492,0.57877,P54802,A681V,Loss of methylation at R676 (P = 0.2112); Gain of catalytic residue at D684 (P = 0.3336); Gain of MoRF binding (P = 0.4604); Loss of helix (P = 0.5596); Loss of stability (P = 0.5758)
V686A,0.44,0.116,V,A,686,17,42544063,T,C,17,40696081,17,37949607,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.063,0.36709,T,0.148,0.27908,B,0.084,0.2927,B,0.702,0.83862,P54802,V686A,Loss of stability (P = 0.0091); Gain of disorder (P = 0.148); Gain of catalytic residue at V686 (P = 0.3582); Loss of helix (P = 0.3949); Gain of glycosylation at S685 (P = 0.5058)
Q688R,0.67,0.062,Q,R,688,17,42544069,A,G,17,40696087,17,37949613,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.515,0.07378,T,0,0.02946,B,0.001,0.04355,B,0.324,0.30537,P54802,Q688R,Loss of loop (P = 0.2237); Loss of helix (P = 0.2662); Loss of relative solvent accessibility (P = 0.3219); Loss of solvent accessibility (P = 0.3473); Gain of MoRF binding (P = 0.3485)
H695Y,0.45,0.12,H,Y,695,17,42544089,C,T,17,40696107,17,37949633,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.027,0.46513,D,0.777,0.44168,P,0.284,0.40463,B,.,.,.,.,.
Q703H,0.46,0.112,Q,H,703,17,42544115,A,C,17,40696133,17,37949659,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.098,0.308,T,0.873,0.47975,P,0.601,0.50808,P,0.508,0.60373,P54802,Q703H,Loss of helix (P = 0.0093); Gain of sheet (P = 0.0507); Gain of ubiquitination at K699 (P = 0.0872); Gain of loop (P = 0.1069); Gain of catalytic residue at E705 (P = 0.2135)
Q703H,0.46,0.112,Q,H,703,17,42544115,A,T,17,40696133,17,37949659,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.098,0.308,T,0.873,0.47975,P,0.601,0.50808,P,0.508,0.60373,P54802,Q703H,Loss of helix (P = 0.0093); Gain of sheet (P = 0.0507); Gain of ubiquitination at K699 (P = 0.0872); Gain of loop (P = 0.1069); Gain of catalytic residue at E705 (P = 0.2135)
V709I,0.62,0.197,V,I,709,17,42544131,G,A,17,40696149,17,37949675,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.486,0.08091,T,0.016,0.17332,B,0.012,0.16012,B,0.614,0.74758,P54802,V709I,Loss of catalytic residue at V709 (P = 0.0212); Loss of ubiquitination at K712 (P = 0.1166); Loss of disorder (P = 0.1979); Gain of helix (P = 0.2059); Gain of methylation at K712 (P = 0.2805)
L710V,0.94,0.147,L,V,710,17,42544134,C,G,17,40696152,17,37949678,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.5,0.07746,T,0.064,0.23455,B,0.059,0.26602,B,.,.,.,.,.
R714M,0.56,0.11,R,M,714,17,42544147,G,T,17,40696165,17,37949691,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.235,0.18,T,0.989,0.62824,D,0.87,0.61806,P,0.524,0.62805,P54802,R714M,Gain of ubiquitination at K712 (P = 0.0581); Loss of phosphorylation at S717 (P = 0.062); Loss of solvent accessibility (P = 0.0674); Loss of disorder (P = 0.0736); Loss of glycosylation at P716 (P = 0.1524)
Q718H,0.81,0.09,Q,H,718,17,42544160,G,C,17,40696178,17,37949704,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.08,0.33585,T,0.013,0.16609,B,0.012,0.16012,B,0.472,0.54685,P54802,Q718H,Gain of methylation at R720 (P = 0.0494); Loss of glycosylation at P716 (P = 0.1258); Gain of disorder (P = 0.1318); Loss of solvent accessibility (P = 0.1551); Gain of helix (P = 0.2684)
Q718H,0.81,0.09,Q,H,718,17,42544160,G,T,17,40696178,17,37949704,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.08,0.33585,T,0.013,0.16609,B,0.012,0.16012,B,0.472,0.54685,P54802,Q718H,Gain of methylation at R720 (P = 0.0494); Loss of glycosylation at P716 (P = 0.1258); Gain of disorder (P = 0.1318); Loss of solvent accessibility (P = 0.1551); Gain of helix (P = 0.2684)
R720Q,,,R,Q,720,17,42544165,G,A,17,40696183,17,37949709,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.662,0.04671,T,0.006,0.13644,B,0.002,0.06944,B,0.415,0.45367,P54802,R720Q,Loss of phosphorylation at T723 (P = 0.081); Loss of catalytic residue at R720 (P = 0.124); Loss of MoRF binding (P = 0.1244); Gain of disorder (P = 0.1496); Gain of glycosylation at P716 (P = 0.1887)
D722N,0.93,0.125,D,N,722,17,42544170,G,A,17,40696188,17,37949714,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.067,0.35918,T,0.977,0.58535,D,0.666,0.5299,P,0.667,0.80493,P54802,D722N,Gain of MoRF binding (P = 0.0377); Loss of phosphorylation at S717 (P = 0.1112); Loss of helix (P = 0.1299); Loss of disorder (P = 0.1374); Gain of loop (P = 0.2045)
K729Q,0.9,0.117,K,Q,729,17,42544191,A,C,17,40696209,17,37949735,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.231,0.18246,T,0.884,0.48618,P,0.462,0.46509,P,.,.,.,.,.
K729R,0.08,0.029,K,R,729,17,42544192,A,G,17,40696210,17,37949736,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.566,0.06262,T,0.007,0.14184,B,0.011,0.15521,B,0.529,0.63547,P54802,K729R,Loss of methylation at K729 (P = 0.0185); Gain of MoRF binding (P = 0.059); Loss of catalytic residue at K729 (P = 0.0865); Gain of ubiquitination at K733 (P = 0.14); Loss of solvent accessibility (P = 0.3543)
F731V,0.76,0.124,F,V,731,17,42544197,T,G,17,40696215,17,37949741,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.029,0.45756,D,0.997,0.70673,D,0.954,0.69447,D,0.782,0.90613,P54802,F731V,Gain of MoRF binding (P = 0.0688); Loss of stability (P = 0.1031); Gain of methylation at K729 (P = 0.1511); Loss of helix (P = 0.2022); Loss of ubiquitination at K733 (P = 0.2684)
P736L,0.73,0.145,P,L,736,17,42544213,C,T,17,40696231,17,37949757,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.007,0.59928,D,0.999,0.77913,D,0.859,0.61184,P,0.486,0.56926,P54802,P736L,Gain of helix (P = 0.0082); Loss of loop (P = 0.0084); Gain of catalytic residue at P736 (P = 0.0098); Gain of ubiquitination at K733 (P = 0.0638); Loss of disorder (P = 0.0796)
R737G,1.08,0.035,R,G,737,17,42544215,C,G,17,40696233,17,37949759,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.042,0.41637,D,0.678,0.41346,P,0.128,0.32786,B,.,.,.,.,.
R737S,0.69,0.09,R,S,737,17,42544215,C,A,17,40696233,17,37949759,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.049,0.3982,D,0.465,0.36447,P,0.07,0.27859,B,.,.,.,.,.
R737H,0.66,0.09,R,H,737,17,42544216,G,A,17,40696234,17,37949760,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.111,0.29029,T,0.033,0.2035,B,0.003,0.087,B,.,.,.,.,.
R737C,0.08,0.043,R,C,737,17,42544215,C,T,17,40696233,17,37949759,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.007,0.59928,D,0.997,0.70673,D,0.549,0.49194,P,0.427,0.47336,P54802,R737C,Loss of MoRF binding (P = 2e-04); Gain of catalytic residue at P736 (P = 0.009); Loss of helix (P = 0.028); Loss of disorder (P = 0.0431); Gain of sheet (P = 0.0507)
A740P,0.59,0.143,A,P,740,17,42544224,G,C,17,40696242,17,37949768,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0.014,0.53172,D,0.553,0.38185,P,0.102,0.30857,B,0.355,0.35559,P54802,A740P,Gain of relative solvent accessibility (P = 0.005); Loss of catalytic residue at A740 (P = 0.0059); Gain of loop (P = 0.0097); Gain of solvent accessibility (P = 0.0137); Loss of helix (P = 0.0237)
G741S,0.94,0.104,G,S,741,17,42544227,G,A,17,40696245,17,37949771,NAGLU,ENSG00000108784,ENST00000225927,ENSP00000225927,P54802,0,0.91255,D,0.016,0.17332,B,0.006,0.12133,B,0.313,0.28763,P54802,G741S,Gain of disorder (P = 0.1018); Loss of loop (P = 0.1242); Loss of catalytic residue at A740 (P = 0.1404); Gain of helix (P = 0.1736); Gain of MoRF binding (P = 0.3361)